Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis

Clinical trial NCT06035055 · UNKNOWN

Trial details

NCT number: NCT06035055
Sponsor: Sunshine Coast Hospital and Health Service
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Bronchiectasis Cystic Fibrosis Pseudomonas Aeruginosa Burkholderia Cepacia Infection

Start date: 2023-10-01
Primary completion: 2023-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.